The observation that a considerable number of GCB and not all non-GCB/ABC DLBCL cells were β-catenin positive indicates that alternative processes besides chronic BCR signaling may contribute to β-catenin stabilization. The gene discussed is BCR; the disease is diffuse large B-cell lymphoma.